Notice of Publication of Interview Related to Clinical Trial for Premenstrual Syndrome/Premenstrual Dysphoric Disorder with Psychiatric Symptoms

Renascience Inc. has been conducting clinical development of pyridoxamine for premenstrual syndrome with psychiatric symptoms / premenstrual dysphoric disorder in collaboration with Tohoku University, Kinki University, Tokyo Medical and Dental University, Tokyo Women’s Medical University, and five additional clinical institutes, as a project of the Cyclic Innovation for Clinical Empowerment (CiCLE) program of the Japan Agency for Medical Research and Development (AMED). We believe that this drug can improve the quality of life of women and significantly contribute to the promotion of the active roles of women in society.

We are pleased to announce that an interview related to this investigator-initiated clinical trial was published in the November 21 issue of Machico, Sendai Town Information.

Please see the link below for the details of the article.